Publications by authors named "Oriella Gnarra"

Article Synopsis
  • The Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) aims to discover new biomarkers for central disorders of hypersomnolence, particularly focusing on narcolepsy type 1 (NT1) and its distinction from healthy controls.
  • Researchers used Fitbit smartwatches to gather data on physical activity, heart rate, and sleep over a year, achieving an impressive adherence rate of 80% among participants.
  • Findings revealed that NT1 patients showed increased sleep fragmentation and specific changes in sleep and heart rate metrics compared to healthy controls, indicating the potential for wearable technology to assist in the diagnosis and management of narcolepsy in the future.
View Article and Find Full Text PDF

Sleep abnormalities may represent an independent risk factor for neurodegeneration. An international expert group convened in 2021 to discuss the state-of-the-science in this domain. The present article summarizes the presentations and discussions concerning the importance of a strategy for studying sleep- and circadian-related interventions for early detection and prevention of neurodegenerative diseases.

View Article and Find Full Text PDF

Patients with Parkinson's disease (PD) tend to sleep more frequently in the supine position and less often change head and body position during sleep. Besides sleep quality and continuity, head and body positions are crucial for glymphatic system (GS) activity. This pilot study evaluated sleep architecture and head position during each sleep stage in idiopathic PD patients without cognitive impairment, correlating sleep data to patients' motor and non-motor symptoms (NMS).

View Article and Find Full Text PDF

Sleep is crucial in rehabilitation processes, promoting neural plasticity and immune functions. Nocturnal body postures can indicate sleep quality and frequent repositioning is required to prevent bedsores for bedridden patients after a stroke or spinal cord injury. Polysomnography (PSG) is considered the gold standard for sleep assessment.

View Article and Find Full Text PDF

Study Objectives: Isolated rapid eye movement sleep behavior disorder (iRBD) is a parasomnia characterized by dream enactment. It represents a prodromal state of α-synucleinopathies, like Parkinson's disease. In recent years, biomarkers of increased risk of phenoconversion from iRBD to overt α-synucleinopathies have been identified.

View Article and Find Full Text PDF

. Learning to classify cardiac abnormalities requires large and high-quality labeled datasets, which is a challenge in medical applications. Small datasets from various sources are often aggregated to meet this requirement, resulting in a final dataset prone to label noise due to inter- and intra-observer variability and different expertise.

View Article and Find Full Text PDF

Neurologic disorders impact the ability of the brain to regulate sleep, wake, and circadian functions, including state generation, components of state (such as rapid eye movement sleep muscle atonia, state transitions) and electroencephalographic microarchitecture. At its most extreme, extensive brain damage may even prevent differentiation of sleep stages from wakefulness (eg, status dissociatus). Given that comorbid sleep-wake-circadian disorders are common and can adversely impact the occurrence, evolution, and management of underlying neurologic conditions, new technologies for long-term monitoring of neurologic patients may potentially usher in new diagnostic strategies and optimization of clinical management.

View Article and Find Full Text PDF

At present, the standard practices for home-based assessments of abnormal movements in Parkinson's disease (PD) are based either on subjective tools or on objective measures that often fail to capture day-to-day fluctuations and long-term information in real-life conditions in a way that patient's compliance and privacy are secured. The employment of wearable technologies in PD represents a great paradigm shift in healthcare remote diagnostics and therapeutics monitoring. However, their applicability in everyday clinical practice seems to be still limited.

View Article and Find Full Text PDF